# Sickness Evaluation at Altitude With Acetazolamide at Relative Dosages

> **NCT03424226** · PHASE1 · COMPLETED · sponsor: **Stanford University** · enrollment: 105 (actual)

## Conditions studied

- Acute Mountain Sickness

## Interventions

- **DRUG:** Acetazolamide

## Key facts

- **NCT ID:** NCT03424226
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-04
- **Primary completion:** 2018-09-30
- **Final completion:** 2018-09-30
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2018-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03424226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03424226, "Sickness Evaluation at Altitude With Acetazolamide at Relative Dosages". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03424226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*